Dr. Kelly McMasters has been named president of the Southern Surgical Association, one of the nation's leading surgical societies dedicated to furthering the study and practice of surgery. Dr. McMasters previously served a five-year term as secretary of the Southern Surgical Association.
Dr. John L. Falcone
A champion of medical education and a patient advocate, clinical faculty member John L. Falcone, MD, MS, was recently recognized for his tremendous contributions as a surgical educator with the Association for Surgical Education Linnea Hauge, PhD Promising Educational Scholar Award. In addition, he has been selected to receive a University of Louisville Gratis Faculty Teaching Award.
At the University of Louisville Department of Surgery, Dr. Falcone has been an integral part of our teaching faculty in the community rotation at Owensboro, KY. The hospital in Owensboro has a regular rotation of general surgical residents who are actively mentored and trained in a comprehensive, community surgical experience. As many academic institutions now lack a meaningful community hospital rotation, Dr. Falcone's leadership of that program has been invaluable to the education of our surgical residents. His teaching evaluations from both the medical students who participate in that rotation as well as our surgical residents are always excellent.
John Edward McKiernan
Beloved former Department of Surgery employee John Edward McKiernan, Jr. passed away Friday, March 1, 2019. He was 78.
A graduate of Flaget High School class of 1958 and Western Kentucky University, John was a proud U.S. Navy veteran and long-time member of St. Barnabas parish.
In the late 1960s John taught commercial business at Seneca, Fairdale, Western and Southern high Schools. He was employed for 20 years at the L&N Railroad and later at the Kentucky Center for the Performing Arts Broadway Series. He retired from the University of Louisville Department of Surgery in 2009 after 12 years of service.
A seasoned world traveler, he was loved and remembered for his passion for dancing, Frank Sinatra music, his larger-than-life personality and generous heart. He possessed a natural gift for conversation and was interested in everyone who crossed his path. In his Flaget days he was the jitterbug king at just about every Catholic teen club in Louisville. He was especially proud of his Irish Catholic heritage and was admired and adored by everyone.
At John's request, expressions of sympathy may be made to Presentation Academy Development Office, 861 South Fourth Street, Louisville, KY 40202.
Debbie Krause, Department of Surgery coordinator, received the inaugural Dean's Lifetime Achievement Award at the UofL School of Medicine Dean's Appreciation Reception, Nov. 13. The Dean's Lifetime Achievement Award was created by School of Medicine Dean Toni Ganzel, MD, as a special recognition for employees who have served the school with excellence for many years. Debbie has worked for the Department of Surgery for nearly 45 years. During her tenure, she has completed a variety of tasks in service to UofL with the greatest loyalty, professionalism, competence and grace.
"Debbie exemplifies the excellence we strive to achieve in the department. Throughout the course of her career, Debbie has always paid meticulous attention to detail and plans well in advance for every possible contingency. She is the consummate ambassador for the University, as she is our liaison with countless other institutions and leaders in American medicine and surgery," said Kelly McMasters, MD, PhD, Chairman of the Department of Surgery. "She exudes warmth for our medical students and residents, as well as new and veteran faculty and co-workers. She remembers the names of their spouses and children, as well as special details about each and every one of them. For her role in coordinating our visiting lectureships and grand rounds programs, Debbie is the perfect host and continually receives letters of praise from visiting professors and their staff."
This year's Society of Surgical Chairs meeting focused on two important topics: Diversity, Equity & Inclusion and Sexual Harassment & Misconduct. Department of Surgery Chairman Dr. Kelly McMasters served as president of the Society of Surgical Chairs and organized this year's meeting.
Diversity, equity and inclusion don't happen by accident; a deliberate approach is needed. Similarly, creating an environment that diminishes the likelihood of sexual harassment and misconduct requires leadership, education and communication," Dr. McMasters said. "As the leaders in American surgery, it is important for the Society of Surgical Chairs to engage in ongoing conversations about these issues.
Dr. Mohan Rao is the recipient of UofL School of Medicine's 2019 Faculty Excellence Award for Outstanding Education by Gratis Faculty.
Dr. Rao completed his General Surgery residency at the University of Louisville and has enjoyed a distinguished career as a general and critical care surgeon. He is a master surgeon with the heart of a teacher and has demonstrated exceptional loyalty and commitment to the University of Louisville School of Medicine.
For decades, Dr. Rao has been the most popular and effective educator in our student teaching program - all as a gratis faculty member. Our general surgery residents also rotate at Madisonville under Dr. Rao's mentorship, and he has truly influenced many to enter into careers in rural general surgery.
Dr. Rao puts forth extraordinary effort to make our student and resident teaching programs better in every way and is truly deserving of this award.
Dr. Robert C.G. Martin, Co-Principal
Investigator of the DIRECT Study
University of Louisville Department of Surgery recently announced enrollment of the first patient in AngioDynamics’ NanoKnife® Irreversible Electroporation (IRE) "Data IRECancer Treatment” clinical study (DIRECT).
The DIRECT Study supports a proposed expanded indication for the NanoKnife System in the treatment of Stage III pancreatic cancer.
"We are pleased to be the first enrolling site. The DIRECT Study represents an important milestone in the standardization of care for patients with Stage III pancreatic cancer. Our goal is to generate important data that should standardize and optimize the use of IRE in the treatment of locally advanced pancreatic cancer, significantly improving outcomes for patients with this late-stage diagnosis," said Dr. Robert C.G. Martin, Co-Principal Investigator of the DIRECT Study, Director, Division of Surgical Oncology
and Professor of Surgery at the University of Louisville and surgical oncologist with UofL Physicians – Surgical Oncology.
AngioDynamics’ DIRECT clinical study features a comprehensive data collection strategy that will provide meaningful clinical information to healthcare professionals, support a regulatory indication for the treatment of Stage III pancreatic cancer, and facilitate reimbursement for hospitals and treating physicians. The next-generation study is classified as a Category B IDE by the FDA, which allows participating sites to obtain coverage for procedures performed in addition to any related routine costs.
"The enrollment of our first patient soon after receiving FDA approval is a strong signal that clinicians are eager to evaluate treatment alternatives that improve the dismal prognosis for Stage III pancreatic cancer patients," said Brent Boucher, AngioDynamics Senior Vice President and General Manager of Oncology. "We look forward to confirming that our proprietary NanoKnife technology offers a compelling alternative to the current standard of care and believe that this study will provide a pivotal dataset for claims and reimbursement purposes."
The DIRECT Study comprises a Randomized Controlled Trial at up to 15 sites, as well as a Real-World Evidence, next-generation registry at up to 30 sites, each with a NanoKnife System treatment arm and a control arm. AngioDynamics expects each NanoKnife arm to consist of approximately 250 patients with an equal number of control patients. The primary endpoint of the study is overall survival.
Department of Surgery is proud to announce the Division of Immunotherapy, which is leading the way to improve our understanding of the role of immunotherapy in the treatment of cancer and other diseases. Our team of researchers is engaged in pioneering research designed to trigger our bodies' own immune system to fight disease.
Dr. Brian Harbrecht, Professor of Surgery in the Department of Surgery at UofL and Director of Trauma Surgery at UofL Hospital, and Dr. Raymond Orthober, Assistant Professor of Emergency Medicine and Medical Director of Louisville Metro EMS, will lead UofL's participation in a Department of Defense (DOD)-funded clinical trial aimed at improving survival among people who have difficulty breathing after a trauma.
UofL will join nearly two dozen emergency medical service agencies across the country in the prehospital Airway Control Trial (PACT), which is an $8.8 million, four-year study, beginning at the end of 2019 that will test different strategies to help patients breathe at the scene of a trauma to see if one works better than another at increasing survival.
This is an “exception from informed consent” trial, which means that since the trial requires performing a potentially life-saving procedure in traumatically injured patients who are too injured to give consent to the trial, they will be automatically enrolled if they fit the criteria. Once patients are stable, they and/or their families will be notified that they were enrolled, and they can opt out of continued participation at that point. Learn more at
The Department of Surgery is excited to welcome alumni Dylan Adamson, M.D., Assistant Professor of Surgery, Division of Transplantation. Dr. Adamson attended medical school at University of Toledo College of Medicine. He then completed his general surgery residency at University of Louisville and a fellowship in Abdominal Organ Transplant and Hepatobiliary Surgery at The Mount Sinai Hospital in New York.
Watch Dr. Kelly McMasters' presidential address.
The Department of Surgery is excited to welcome Tyler Ellis, MD, MSCR, to the Colon and Rectal Surgery Section of the Division of General Surgery. Dr. Ellis attended medical school at Medical University of South Carolina in Charleston, SC. He then completed his general surgery residency at University of North Carolina at Chapel Hill and a fellowship in colorectal surgery at University of Massachusetts in Worchester, MA. He also has a fellowship in clinical research from Medical University of South Carolina.
Christopher 2X Game Changers along with gunshot wound survivors treated at UofL Hospital recognized the trauma team at UofL for their life-saving care for gunshot wounded victims from 2003-2019.
The trauma team at UofL includes numerous trauma surgeons, nurses and staff who dedicate their lives to saving others. Since 2003, they have treated more than 3,000 victims of gun violence.
All four local news stations ran stories on the event. Click below to watch the coverage:
The Division of Vascular Surgery in the Department of Surgery at University of Louisville School of Medicine is proud to announce that we will offer a fellowship in Vascular Surgery in the very near future. Check back here for updates. The Division of Vascular Surgery and Endovascular Therapeutics is a dynamic academic division of the Department of Surgery. It has a tripartite mission that includes the provision of clinical care and services, conduct of clinical and translational research, and education, which includes undergraduate medical, graduate, and continuing medical education.
Dr. Annie Nagengast
UofL Department of Surgery's very own Administrative Chief Resident Annie Nagengast, MD appeared on Wheel of Fortune. She had some great things to say about the Department. Click below to watch.
Congrats to the following physicians named Louisville Magazine's Top Docs in their respective categories:
View the full list of Top Docs on Louisville Magazine's website.
Dr. Gordon Tobin, professor of plastic and reconstructive surgery, will receive Kentucky Medical Association's 2019 Distinguished Service Award on Sept. 21, 2019. Dr. Tobin is recognized for his significant contributions to the field of medicine.
Dr. Tobin's career encompasses surgical education, pioneering medial research, care for the underserved at home and abroad and physician leadership in local, state and national organizations. Professor of Surgery and former Plastic Surgery Director, he founded a robust research laboratory that developed many new reconstructive techniques and pioneered hand and face transplantation. He is Director of Craniofacial Transplantation at UofL and an original member of the team that laid essential research foundations and performed the world's first successful hand transplant in 1999.
Matthew Benns, M.D.
Dr. Matthew Benns, Assistant Professor of Surgery,
Division of General Surgery, has been elected as Vice Chief of Staff at University
of Louisville Hospital. The active medical staff members were asked to nominate
individuals who were practicing physicians and full-time faculty members of the
UofL School of Medicine but not a department chair. Dr. Benns' position has a three-year
Sheldon Bond, M.D.
Dr. Sheldon Bond has been selected to receive the 2016 KMA Educational Achievement
Award. Dr. Bond has been Director of Student Teaching Programs in the Department
of Surgery for the past decade. He also serves as Assistant Dean for Clinical Education.
He is a Professor of Pediatric Surgery.
Dr. Kelly McMasters
It is my great honor to give the commencement address for the UofL SOM class of 2017. Twenty-eight years ago, I graduated from medical school, and I remember the overwhelming sense of pride and accomplishment in finishing medical school, the relief of never having to study the Krebs cycle again, the excitement of moving to a different city in a different state far from home to begin residency training, of having to start fresh to develop a whole new set of friends and colleagues, the thrill of finally becoming a real doctor balanced against the anxiety and fear of that solemn responsibility—of the knowledge that my decisions and actions could save lives, and my mistakes could cost them. I remember that tangled mass of emotions like it was yesterday. But what I do not remember at all, I assure you, is who the commencement speaker was at my graduation, or what he or she said. I’m holding all of you to a higher standard.
Each year at my house, we host a party for the new interns. Faculty and residents generally attend, drink a couple beers, eat too much food, and help the new interns celebrate the last few hours of their freedom before starting a challenging 5 to 8 year general surgery residency program. As tradition would have it for the past dozen years, the new interns all volunteer to participate in a (mandatory) low-stakes poker game—Texas Hold ‘em.
Why do we ask the new interns to play in a poker game just before they take their first night on call, when they will hold the fate of patients in their hands, when their thoughts and deeds could mean the difference between life and death? Shouldn’t they be studying anatomy or the Krebs cycle or something important? Perhaps there are many hidden lessons to be learned from this simple game of poker.
In poker, there are only 3 possible actions--3 possible choices: check (do nothing), bet (or raise, which is just betting more than the player before you), or fold—check, bet, or fold, those are your only options. It would seem that the person with the best poker hand should always win. Ahhh, but if that were true, poker would just be a game of chance. In fact, the person with the best hand frequently loses, because it is much more important how well you play the cards you are dealt than how good your cards actually are. The most dramatic moment of a game of Texas Hold ‘em is when the player pushes all of his chips to the center of the table, betting all of his remaining money, and goes "all in." At this moment, the player going "all in" realizes that there is no turning back, that she is committed to action that likely will result in either doubling her money (at least), or losing it all.
What is the point of this poker game, you might be asking yourselves? All of human interaction is a negotiation of sorts—for resources, attention, recognition, prestige, status, power, and even love. The three basic choices--check, bet, or fold--are fundamentally synonymous with all of the important decisions you will ever make, and form the basis for all human interaction. Perhaps I’m overanalyzing the cosmic significance of a poker game, since I only get to play once a year with interns, but here goes:
Poker Lesson #1. You win more pots by betting than by checking, and you never win if you fold.
Sometimes it is better to decide upon a course of action and pursue it, even if the end result is unsatisfactory. It is frequently said that: "More harm is done by a timid surgeon than a bold one." Surgeons are also often said to be "frequently wrong but never in doubt." Action usually trumps inaction, and no decision is frequently worse than the wrong decision. The same holds true of many of the other decisions you will make in life and in your career. Be bold, be decisive, and never quit as long as you have a chip and a chair, or your patient has a pulse and a blood pressure.
Poker Lesson #2. You have to play the cards you are dealt.
You don’t get to choose what cards you are dealt any more than you get to choose who your patients are, what their comorbidities are, or who their families are. You don’t get to choose the circumstances and obstacles that come your way. Sometimes you are dealt a losing hand that you can win. Sometimes you are dealt a winning hand that you lose. Play the cards you are dealt, and decide when it’s time to check, bet, or fold. If you always fold when you are dealt 10-2 offsuit—that is, if you can’t sometimes find a way to turn bad circumstances into opportunity—you will have a difficult time in your career and in your personal life.
Poker Lesson #3. You never win if you fold, but sometimes it’s better to live to play another hand.
Decisions in life to go "all in" should be made judiciously—you have to be prepared to lose it all. Choose your battles carefully, don’t wage war on too many fronts, and don’t fight battles you can’t win. When facing difficult situations, I often ask myself: "is this the hill I want to die on?" Sometimes strategic inaction is better than action, although this is an acquired skill for surgeons.
Admittedly, my poker analogies were really just a way of easing into the more difficult part of this commencement address, which is entitled: "Reflections from the Other Side." I neglected to say: from the other side of what? I’m fairly sure you didn’t expect me to talk about reflections from the other side of the poker table. And no, I haven’t seen the light at the end of the tunnel, nor have I had a glimpse at what is on the other side of this life. Nevertheless, I certainly have had some time to reflect on what is important in this one—especially on what is important to being a good doctor and decent person. I make no claim to be either. The only thing I claim is that at least I have had a few years longer than you to consider these issues, in the hope that I can learn from them.
So here are the lessons I want to highlight for you today:
When walking the tightrope, don’t lose your balance.
I am a Surgical Oncologist—I operate on patients with cancer for a living. I have spent my entire adult life either training to be a cancer surgeon or being one. Surgical Oncologists focus on doing whatever it takes to cut out cancer. We excise, resect, ablate, and otherwise extirpate cancer. Surgery is still the most effective cancer therapy ever invented. We appreciate the help of our medical oncology and radiation oncology colleagues to help improve the odds of curing patients, but make no mistake—surgery is the primary treatment for most types of cancer. Perhaps that will change in the future, and I certainly hope so.
Surgical oncologists focus intensively on doing what needs to be done to cut out the cancer. There is something innately gratifying in grappling with tumors and removing them with your bare hands (Ok, maybe with a few instruments, and with gloved hands). You get the point. Surgical steel vs. tumor—the battle is on. Many patients recover from surgery uneventfully and are cured of their cancer. Occasionally, patients will die because of the operations we perform. Not uncommonly, patients experience major complications and problems. We sometimes take big risks to achieve big rewards. Or sometimes we push "all in" and lose.
Before we see our cancer patients, we look at their x-rays. We want to see pictures of the cancer and stare it down--take its measure. We assess the patient’s comorbidities and risks of surgery. At times, it can seem as if we are treating a cancer that just happens to have a person attached to it. Physicians (even surgeons) are human. We protect ourselves using primal defense mechanisms because no human being could withstand complete empathy with an entire office full of patients suffering from cancer. No matter what specialty you are entering, you must resist the natural tendency to treat the disease and not the patient.
I remember when this realization first smacked me in the face. I’m going to tell you a story that I have never told to anyone. I was a surgical oncology fellow at MD Anderson Cancer Center in Houston. The fellows thought we were like Tom Cruise in the movie "Top Gun," learning to be the biggest, baddest cancer surgeons in the country. We bragged to each other about the complex, difficult cancer operations we performed.
I had performed a forequarter amputation on a patient with sarcoma. Forequarter amputation is removing the entire arm and shoulder, in this case, part of the chest wall and rib cage as well. Now that was just the kind of big, gruesome cancer operation I went there to learn how to do.
The patient was a 19 year-old young lady from Spain. She didn’t speak English, and I didn’t speak Spanish. She was beautiful in every way. She had shimmering dark hair, striking perfect features, and piercing, soulful dark eyes. She was immensely courageous, and prepared herself for this life-changing cancer operation with uncommon grace, dignity, and fortitude.
While making morning rounds on postoperative day #1, I examined the patient, checked her incisions, witnessed the mutilation we had caused, then looked into those dark eyes, and saw that the light in those eyes had dimmed—her soul was crushed. Overcome with emotion, I exited quickly and walked to the nearest stairwell and sobbed piteously, having glimpsed into the eyes of this girl who spoke a different language but communicated so well. I wept in anguish and disgust for what we had done to this young lady, knowing that we had little choice but to attempt to remove her limb to try to save her life. I don’t know what became of her, but I think of her often.
At the time, I was ashamed of my stairwell breakdown. Surgeons don’t cry. Human beings do. These days, I would be ashamed if I hadn’t felt this emotion so strongly, and would be concerned if this no longer bothered me.
There is often a very fine line in medicine between benefit and harm. No matter what field of medicine you practice, you will be faced with impossible choices. You must decide when to check, bet, or fold. You will make mistakes, and they will have serious and sometimes fatal consequences. The mark of a physician’s character is in how he or she deals with his or her mistakes. Own your mistakes, admit them, learn from them, and use them to become better. You will lose your share of battles. Soldier on, and continue to fight the good fight.
We as physicians are forced to walk this tightrope on a regular basis.
So remember, when walking the tightrope, don’t lose your balance.
As many of you know, my son, Owen, died last year after a 5-year battle with leukemia. When he was first diagnosed, I knew virtually nothing about leukemia. I remembered nothing about it from medical school. All I knew was that leukemia was one of those cowardly blood cancers that surgeons couldn’t cut out.
As far as I can tell, the strategy for treating childhood leukemias is to give every toxic drug that a child could possibly tolerate in the hope that the child is stronger than the cancer. The treatment regimen was brutal. Innumerable chemotherapy drugs that made his hair fall out multiple times over the years, made him sick and weak, prone to life-threatening infections that he dealt with multiple times, drug reactions, intrathecal chemotherapy injected into the spine on a regular basis, high-dose steroids that made him bloated and miserable. The vicious cycle of apparent remission followed by relapse. Many days and nights, every major holiday it seemed, spent in the hospital. Bone marrow transplant that didn’t cure the cancer. More chemotherapy, more toxicity, experimental therapy--eventually peace.
So yes, I’ve seen the other side—the other side of the patient’s room, looking out of the doorway instead of looking in. I had never really been the patient before. I had never been the family member before. I had only been the doctor.
Here are some other lessons I learned from the other side of the patient’s room:
Any night on a flat surface is a good night
My wife, Beth, and I have spent countless nights sleeping in a pediatric hospital room—well over 100, I have no idea how many. We were confined to a hospital room or ICU room, often for weeks at a time. I was one of those family members you have seen when making rounds in the morning darkness, in your way as you try to examine the patient--asleep in a chair, on the floor, in a cot, or every conceivable type of contraption that hospitals provide for family members to sleep on. The chair-type things are impossible to sleep in, like sleeping in the center seat in the coach section of a red-eye flight. I was the family member with crumpled clothing, uncombed hair, unwashed and unshaven in the morning. You might have found me snoring ignobly, dead to the world. When Owen needed me in the middle of the night, he often had to throw something at me to wake me up. Fortunately, he kept throwable objects close by at all times. More often, however, I would be waiting for you--residents and fellows--wanting to make sure that you had all the important information about Owen’s status since the prior day. I always tried to be cordial, professional, or even friendly in these interactions with the health care team. It was a lot easier to be congenial if I had gotten a couple of hours sleep on a flat surface.
Remember, family members are under an enormous amount of stress caring for their loved ones. Sometimes the stress is too much, and they will seem accusatory, frustrated, angry, or full of contempt. They might become overwhelmed with emotion and need to find a stairwell. Don’t mistake their disheveled appearance, anxiety, fear, and questions and label them as "difficult patients" or "difficult families." They are concerned about their loved ones. The louder and more agitated they get, the softer and calmer you must be. You will be in their shoes some day.
And remember, any night on a flat surface is a good night
An ounce of empathy is worth a thousand pounds of apathy.
For any of you who will enter the field pediatric oncology or be involved in treating children with cancer, you have my deep admiration. As a surgical oncologist, I treat mostly old people with cancer. That is child’s play compared to treating childhood cancer. Owen was fortunate to have wonderful doctors, almost without exception. Throughout the course of his disease, we experienced the difference between empathy and apathy. It does not take much effort to express a little bit of empathy. A little eye contact, smile, kind word or gesture is all it takes. It is immensely soothing to patients and their families. If you are looking at the chart, or these days typing into an electronic medical record, and not looking at the patient, you are making a big mistake. Patients and families can smell your apathy from a mile away. On your worst days, when you have been up all night, and have given everything you have to give, you must still act professionally, even if sometimes it is just an act. Sometimes you just might need to bluff.
Also, never forget that you are not on the front line in terms of the exchange of emotional energy. Doctors make rounds, and have limited time with patients and families--often just a few minutes per day. Doctors write orders, nurses care for patients. Nurses know about empathy. Respect that.
And remember, an ounce of empathy is worth a thousand pounds of apathy.
Sweat the small stuff.
At one point in his treatment, Owen developed a pneumothorax--a collapsed lung--requiring a chest tube. This recurred a couple more times. Because of a persistent air leak, this last chest tube stayed in for a couple of weeks. The new doctors in the audience understand that it is not pleasant to live with a chest tube. Owen’s doctors responsible for this would check in periodically, but not every day, because he still had an air leak and the chest tube obviously needed to stay in.
It turned out that the air leak wasn’t from Owen’s lung. It was a leak from the tubing connections. The chest tube stayed in for much longer than necessary because of inattention to detail. I was very angry with myself for not figuring this out sooner. But I was just the parent. I shouldn’t have to figure it out.
The moral of this story is that the little things matter. Meticulous attention to every detail of patient care, every test, every x-ray, and actually performing a history and physical examination. As we frequently see in Surgery Morbidity and Mortality Conference, there is no procedure so trivial, no detail so small, that it can’t make a big difference in patient outcomes. During my training, I got in the surgical habit of making rounds early in the morning every day. Many people no longer do this. It is a routine, an act of discipline that gets my day off to a good start—to make sure my patients are OK and deal with any problems they may have before anything else happens that day. See your patients every day. Develop good habits. When you are on your way home and you get that nagging feeling that you should have gone back to check on that patient one more time, turn around and go see the patient. When you are on call and the nurse calls you about a patient and the easy thing is to give a verbal order and go back to sleep, get up and go see the patient.
And remember, sweat the small stuff, because it makes a difference. If you can’t handle the small stuff, you will not be prepared for the big stuff.
Don’t avoid the hard conversations
I have taken care of cancer patients my entire life. I tell my patients with serious cancers that I will follow them until I die. We develop a long-term relationship. Many are cured by surgery. Some are not. When the cancer recurs, they usually come back to see me to ask my advice about treatment. I tell them that if it gets to the point that further treatment (chemotherapy) is not going to help, I will tell them. When it gets to that point, I do tell them. Part of my job--often the most difficult, but the most rewarding part--is to ease patients to the other side with dignity.
You would be amazed how often no other doctor is willing to have this conversation with the patient. Hope is a precious thing for patients to cling to, but false hope is just that—false. Learn the difference. It shouldn’t be so hard for physicians to tell the truth. Patients and their families want to hear the truth, and they are eternally grateful to you for telling it. You don’t have to bludgeon people with bad news; learning to deliver bad news with compassion requires some practice. I was never ready to hear the truth about Owen, but I’m grateful to have had a doctor who could tell it.
So remember, don’t avoid the hard conversations.
Aim small, miss small
Each of you is about to embark on an exciting journey to define the purpose of your life. You have studied long and hard, have prevailed against many obstacles, and have demonstrated exceptional tenacity and determination to accomplish the goal of graduating from medical school.
And now, all of that is meaningless.
What I mean by this is that it doesn’t matter where you grew up, where you went to college, where you went to medical school, or whether you were at the top or the bottom of your medical school class. From here on, the slate is wiped clean. You will be on equal footing with all of your fellow residents. You have equal opportunity to excel, to be mediocre, or to fail.
Residency is hard. Life is hard. But none of you has chosen an easy path, and all of you understand the value of self-sacrifice to achieve your goals.
It is easy to get lost in the crowd and never aspire to be anything but average--to be just good enough. Each of you is capable of achieving great things in your chosen specialty--of making a lasting difference in your community, your region, your country, your world. Most people will tell you to aim high. But if you aim high and miss your target, you fail. I would say: aim small, miss small. That means, if you focus intensively on your target, even if you miss the target, you get close enough to be successful. Set big goals, but focus on small targets.
Excellence is the result of discipline, study, hard work, practice, and the drive to become the best. You have come too far to just become an average doctor. You now have the opportunity to make a difference. Don’t squander it.
Good enough is not good enough. Aim small, miss small.
I confess that even though I have seen the other side, I need constant reminders to try to apply these lessons in my own life. So I will take no offense if--many years from now, or even just a couple of hours from now--you have no recollection of this address or who gave it. But maybe, just maybe, you will hold onto a few bits and pieces of this commencement address, and, despite all of the pressures of medical practice and complexities of your personal lives, will remember why you went to medical school in the first place, and what it means to be a good doctor. Remain mindful of what is on the other side.
It has been my great honor to deliver this commencement address. I played for you the cards I was dealt. I showed you my hand. Now you must decide how to play yours. I wish each of you success and happiness in your personal and professional lives.
The Department of Surgery held the inaugural R. Neal Garrison MD Lectureship Feb. 15 and 16, 2018. The speaker was Charles M. Miller, MD, program director for liver transplantation at the Cleveland Clinic.
Dr. Garrison was a Professor of Surgery and Professor of Physiology and Biophysics in the Department of Surgery for 35 years.
During his distinguished career, Dr. Garrison served as Chief of Surgery for 12 years, Associate Dean for Veterans Affairs & Acting Chief of Staff at the Veterans Administration Medical Center. In addition he directed the Department of Surgery Undergraduate Surgical Education curriculum for eight years. In the eighties, he was instrumental in developing the abdominal organ transplant program for the Department of Surgery. He was the co-founder of the Kentucky Organ Donor Affiliates (KODA) in 1987 and continued as its Medical Director. He was named a University of Louisville Distinguished University Scholar from 2008 - 2015.
Dr. Garrison was an active clinical surgeon in the fields of general, vascular and trauma surgery. In addition, he maintained an active bench research laboratory focused on organ blood flow during shock and infection. He received multiple peer-reviewed grants from the National Institutes of Health, American Heart Association, Surgical Infection Society, Department of Defense, and VA Merit Review since 1983. In the laboratory he mentored more than 40 research fellows, surgical residents and doctoral candidates. Throughout his career Dr. Garrison published more than 300 peer- reviewed scientific articles, abstracts & book chapters and has served on the Editorial Board or as reviewer for 12 scientific journals. In 2012, he received the Excellence in Research Award at the Jewish Hospital & St. Mary's Foundation Doctors' Ball.
Dr. Garrison has been a member of 28 medical/surgical professional organizations & an officer of more than half of them. He was President of the Association for Academic Surgeons and served as Chairman or Vice- Chairman of committees for virtually all of these groups. He completed a six-year term as Governor of Kentucky to the American College of Surgeons. He received multiple honors & awards including the Hiram C. Polk Jr. Award for Resident Teaching Excellence on three occasions and was elected by the Louisville Surgical Society as the 2006 Yandell Lecturer and Medal recipient.
In 2015, KODA pledged $100,000 to establish the R. Neal Garrison, M.D. Endowed Surgical Lectureship Fund in honor of Dr. Garrison's role in co-founding KODA and the important work he has accomplished related to transplantation in Kentucky.
Jorge G. Gomez-Gutierrez, Ph.D.'s project entitled “Targeting melanoma hypoxia with
lactic acid bacterium L. lactis” has been selected for a National Institutes of
Health grant. Hypoxia is a component of the tumor microenvironment, which reduces
efficacy of both immuno- and chemo-therapies resulting in poor clinical outcome.Dr.
Gomez-Gutierrez will exploit the hypoxic microenvironment as a target for gene therapy,
utilizing commensal facultative anaerobic bacteria. The overall goal of this project
is to develop an effective and safe delivery system for cancer gene therapy by targeting
the hypoxic tumor microenvironment with food-grade lactic acid bacteria (LAB) Lactococcus
lactis (L. lactis). Dr. Gomez-Gutierrez is an Assistant Professor in the Division
of Surgical Oncology.
Michael Hughes Jr., MD
People with a debilitating and painful disease have a new treatment option available to them.
Michael Hughes Jr., MD, assistant professor of surgery, Division of Transplantation is part of a team of physicians providing total pancreatectomy with islet cell auto-transplantation for some patients with chronic pancreatitis. Since the start of the year, six patients have undergone the procedure and all have functioning islet cells. The program is funded by an $800,000 grant from the Jewish Heritage Fund for Excellence.
Chronic pancreatitis, inflammation of the pancreas, can only be cured with complete removal of the pancreas (total pancreatectomy). However, removing the entire pancreas creates diabetes that is extremely difficult to control, with alternating very high and dangerous, life-threatening low blood sugars. Therefore, only a portion of the pancreas typically is removed in an attempt to prevent post-operative diabetes. This treatment does not very effectively treat the episodes of pain that lead to recurrent hospital admissions for patients with chronic pancreatitis.
The total pancreatectomy with auto-transplantation of islet cells from the pancreas is an alternative treatment being performed by a handful of facilities around the world. This procedure involves complete removal of the pancreas. The patient's islet cells are isolated in a "cleanroom" facility at the Cardiovascular Innovation Institute (a partnership between UofL and the Jewish Heritage Fund for Excellence) and then re-implanted into the patient to prevent diabetes.
"Chronic pancreatitis is a disabling disease that results in constant, unremitting pain" said Dr. Hughes. "Until now, we have been unable to safely perform these procedures. Islet cell auto-transplant immediately following total pancreatectomy allows us to do this."
To learn more, please visit, http://louisville.edu/medicine/news/
Dr. Jarrod Little
A woman who survived a rare childhood cancer successfully underwent a first-of-its-kind procedure to help restore her appearance.
Dr. Jarrod Little, Assistant Professor, Division of Plastic and Reconstructive Surgery, used fat grafting from Janna Coleman's identical twin, Jessie, to reshape Janna's face from the damaging effects of radiation and chemotherapy. While fat grafting has been done for years, there are no instances in medical literature of it taking place from one person to another and never before on identical twins. While tissue from twins has been used for organ transplants, soft tissue procedures between twins are rare, said Dr. Little.
The surgery took place at University of Louisville Hospital over about three hours and was a success.
"It will make a huge difference for her," said Dr. Little. "She looks like a new person. I'm very happy with the results."
Janna, 28, was diagnosed with an aggressive rhabdomyosarcoma at the age of 7. Childhood rhabdomyosarcoma is a disease in which malignant cells form in muscle tissue, and Janna's formed behind her jaw. She was successfully treated, but the surgery, radiation and chemotherapy to her head and neck left lasting effects, damaging her pituitary gland, which disrupted her growth, most noticeably around her face. Her jawbone never grew to an adult size.
While Janna is an identical twin, her sister, Jessie, did not have the same condition. Though they once looked so much alike even their father had trouble telling them apart, after her treatment Janna no longer looked as much like her sister.
"The cancer was the easy part, the aftermath is what's been hard," Janna said.
Janna went through more than 10 reconstructive surgeries over the years to help but without much success. After moving to Louisville and working as an oncology nurse, she heard of Dr. Little and went to him to see if there was anything else that could be done.
With the jawbone in her face damaged and stunted from radiation, Dr. Little determined reconstruction of her jaw was not an option. Fat grafting to help re-shape her face was, but Janna did not have enough fat and was unable to gain weight because of her development issues. But when Dr. Little learned Janna was an identical twin, he came up with the idea to take fat from Jessie and transplant it into Janna's face. The procedure was also unique in that many people with Janna's condition and location of her tumor do not survive to adulthood.
By increasing volume to the face and repairing some of the damaged tissues, the goal of the procedure was to give Janna's face a more natural volume and contour so the size of the jaw bone will not be as noticeable, Dr. Little said.
Fat was also a good option for Janna because it has a high concentration of stem cells, which are beneficial because they can form into new types of cells. When they are introduced to a new area, they can regenerate surrounding soft tissue. And with the twins having a nearly 100 percent genetic match, the probability of success was high.
"I just want to look like my sister and more like a twin," Janna said. "It is hard being her twin. She's gorgeous."
To donate fat, Jessie had to make an effort to gain weight. For months, the normally health-conscious Jessie ate high-calorie foods - including ice cream, pizza and fast food - to develop enough fat that could be removed by liposuction for Janna.
"She's my sister, my twin," Jessie said before the surgery. "Of course I'm going to do anything I can to help."
It will take several months to assess the full effects of the procedure. One or two more sessions may be needed before the reconstruction is complete.
"I want her to be more confident in herself and be proud to say we're twins and not be shy about it because we're exactly alike."
Kelly M. McMasters, M.D., Ph.D.
Dr. Kelly McMasters was recently elected President of the Western Surgical
Association at the Western's Annual Meeting in Coronado, Calif. Dr. McMasters is
the Ben A. Reid, Sr, M.D. Professor and Chairman of the Department of Surgery. The
Western Surgical Association is dedicated to the cultivation, promotion, and diffusion
of the art and science of surgery, to the sponsorship and maintenance of the highest
standards of practice and to the delivery of the best possible care for the public.
Dr. Kelly McMasters
The Society of Surgical Oncology announced Kelly M. McMasters, MD, PhD as the new Editor-in-Chief of Annals of Surgical Oncology (ASO) effective March 2018. Dr. McMasters
becomes only the second Editor in the journal’s nearly 25-year history to assume
the role. He will oversee the print and online editions of ASO and with Mark Roh,
MD, Executive Editor, will lead a prestigious editor roster of expert leaders in
surgical oncology, including more than 20 section editors and associate section
editors from around the world, as well as U.S.-based associate and deputy editors.
Dr. McMasters begins his position on March 23, 2018 in conjunction with the journal’s
25th anniversary and the retirement of Charles M. Balch, MD, who established the
prominence of the publication in the field of surgical oncology. Dr. McMasters will
report directly to the SSO Executive Council and will carry out editorial responsibilities
from his office in Louisville, KY.
"Annals of Surgical Oncology has a rich
heritage as the premier source of clinical and translational science related to
cancer surgery and multidisciplinary care. It is an honor and a privilege to lead
an outstanding editorial board into the future," said Dr. McMasters.
ASO is the worldwide journal of choice of surgical oncologists and is the official
journal of the Society of Surgical Oncology and the American Society of Breast Surgeons.
According to Thompson-Reuters, in the 2016 impact factor ranking among all surgical
oncology scholarly periodicals, ASO has the most citations of all surgical journals
in the world, the highest number of source items, and a current impact factor of
4.041. The journal promotes clinical and translational cancer research, with an
emphasis on clinical trials. Leading subject areas of ASO include Gastrointestinal
Oncology, Breast Oncology, Hepatobiliary Tumors, Colorectal Cancer, Thoracic Oncology,
and Translational Research. ASO strives to enhance the quality of life and survival
of the surgical patient with cancer and to improve the practice environment in which
high-quality surgical oncology care is delivered. ASO also facilitates the career
development of surgical trainees and their transition into academic and community-based
practice and publishes timely articles about public policy and patient advocacy
issues related to the surgical patient with cancer.
Kelly M. McMasters, MD, PhD, will be awarded the Ephraim McDowell Physician
of the Year at the 2016 Jewish Hospital & St. Mary’s Foundation’s Doctors' Ball,
which will be held Saturday, Oct. 15 at the Marriott Louisville Downtown.
The Ephraim McDowell Physician of the Year honors a physician who has made significant
contributions to the field of medicine, provided humanitarian service, and demonstrated
the highest ethical standards. This is typically a physician who has shown long-term
service to the community.
Dr. McMasters leads the Department of Surgery with more than 50 full-time faculty
members, two residency and six fellowship programs. A prolific researcher, dedicated
educator, and seasoned administrator, Dr. McMasters greatly enjoys caring for complex
surgical oncology patients. He has a busy clinical practice that spans most of the
field of surgical oncology, including melanoma, breast cancer, sarcoma, gastrointestinal
malignancies, as well as liver, pancreatic and biliary tumors.
“This field is full of opportunities – to do research, to teach, to provide care
– but at the end of the day, there is just something good about cutting someone’s
cancer out. It’s that simple. Many more solid tumors have been cured because a surgeon
cut out the cancer than by all of the chemotherapy and radiation therapy put together,”
Dr. McMasters graduated with honors from Colgate University. He completed the M.D./Ph.D.
program at the University of Medicine and Dentistry of New Jersey Rutgers Medical
School, with a Ph.D. in Cell and Developmental Biology from Rutgers University.
After completing general surgery residency at the University of Louisville, he performed
a fellowship in Surgical Oncology at the University of Texas-M.D. Anderson Cancer
Center in Houston. In 1996, he joined the faculty of the University of Louisville
as the Sam and Lolita Weakley Professor of Surgical Oncology. In 2005, he became
the Ben A. Reid, Sr., M.D. Professor and Chairman of the Department of Surgery.
Dr. McMasters is the author and principal investigator of the Sunbelt Melanoma Trial,
at the time the world’s largest melanoma study (involving more than 3,600 patients).
He also initiated the University of Louisville Breast Cancer Sentinel Lymph Node
Study, a 4000+ patient multi-institutional study that helped bring widespread acceptance
of this minimally invasive procedure for the staging of breast cancer. His laboratory
research interest has been in developing gene therapy approaches for the treatment
of cancer, as well as discovery of cancer biomarkers. His research has been funded
by the American Cancer Society, the NIH, and other organizations over the past 20
Dr. McMasters has published nearly 400 articles in the peer-reviewed literature,
over 20 book chapters, and a book on hepatocellular carcinoma. He has presented
his research at a multitude of national and international meetings and has served
as a visiting professor at many of the world’s finest institutions. He served as
the 2009-2010 President of the Southeastern Surgical Congress. He is currently President-Elect
of the Society of Surgical Oncology, Secretary of the Southern Surgical Association,
Recorder of the Western Surgical Association, Secretary-Treasurer of the Society
of Surgical Chairs, and Deputy Editor of Annals of Surgical Oncology. He is a member
of many other professional and scientific societies, including the American Surgical
Association, American College of Surgeons, Society of University Surgeons, Association
for Academic Surgery, American Association for Cancer Research, American Society
of Clinical Oncology, Surgical Biology Club, Halsted Society, and International
Surgical Group, among others.
A fundamental shift in how cancer research is conducted and how cancer care is delivered
in the United State is required in order to deliver on the US Cancer Moonshot initiative,
according to a major new report published today in The Lancet Oncology journal.
The report sets out a detailed roadmap to deliver on the Blue Ribbon Panel recommendations,
including a focus on prevention, a new model for drug discovery and development,
a vast expansion of patient access to clinical trials, and an emphasis on targeted
interventions to improve cancer care for underserved groups, specifically children,
cancer survivors and minority groups. The report emphasizes the importance of addressing
health disparities in all recommendations.
The Lancet Oncology Commission on Future
Research Priorities in the USA is authored by more than 50 leading oncologists in
the United States, including Dr. Kelly M. McMasters and other members of leading US cancer organizations,
and sets out 13 key priority areas, each with measurable goals, to focus the $2
billion of funding released to the National Cancer Institute as part of the 21st
Century Cures Act.
It highlights how technological advances, including understanding and mapping pre-cancer
biology and the rapid adoption of big data, as well as new collaborations across
industry, patient groups, academia, government and clinical practice will be critical
to advancing research, and ultimately improving patient care.
"Among the thousands of technical details necessary for the success of an actual
Moonshot, some fundamental principles remained the same; chief among them was the
necessity of reaching the moon. The Commission brought together experts from across
the spectrum of oncology research to help define the proper trajectory for the mission
ahead," says McMasters, President, Society of Surgical Oncology and Ben A. Reid,
Sr., MD Professor and Chairman, The Hiram C. Polk, Jr., MD Department of Surgery,
University of Louisville School of Medicine.
The Commission was launched on Nov. 1 at an event on Capitol Hill, Washington, DC
and will be presented on Nov. 3 at the United Nations Association of New York Humanitarian
Awards, where former Vice President Joe Biden is being honored for his work on improving
cancer outcomes as part of the US Cancer Moonshot Initiative.
For access to the report, please visit: www.thelancet.com/commissions/usa-oncology
Dr. Kelly McMasters has been named president of the Society of Surgical Chairs (SSC),
an international organization comprised of chairs of departments of surgery and
surgical specialty departments of medical schools, academic medical centers and
teaching hospitals of the United States and Canada. The purpose of the SSC is to
cultivate and enhance academic surgery. The SSC is a managed program of the American
College of Surgeons.
Owen Frederick McMasters
Owen Frederick McMasters, 16, passed away Feb. 15, 2016 at home surrounded by his
loving family following a courageous four-year battle with leukemia. He will always
be remembered for his dedication to helping other children with cancer.
Click here to read Owen’s obituary.
Click here to read Dr. McMasters’ eulogy to his
son, which was shared at his funeral.
Chairman of the Department of Surgery, Dr. Kelly McMasters, announced on October 17, the Owen’s Wish Fund for Cancer Immunotherapy Research of the J. Graham Brown Cancer Center.
His son Owen died February 15, 2016 following a courageous four-year battle with leukemia.
"Owen died of leukemia knowing that the science that could have cured him of his cancer was right at our doorstep," McMasters said. "Owen’s wish was that no other children (or adults) would have to endure the ravages of cancer and its treatment without a meaningful chance to be cured."
Cancer immunotherapy has revolutionized the treatment of many types of cancer by harnessing the power of the human body's immune system to eradicate cancer. The Owen’s Wish Fund will allow the Brown Cancer Center to develop a world-class group of scientists and physicians dedicated to advancing the field of cancer immunotherapy and providing state-of-the-art immunotherapy care for patients in our region.
To donate, please visit click here. Under "Designations," click on "Select the fund(s) for your gift," which is in red. Then click "Other," and then in the line under that type "The Owen's Wish Fund."
The Price Institute of Surgical
Research held a reunion Sept. 7 - 9 in honor of its 60th Anniversary. More than
30 people attended, including former Price fellows from all over the world. Additionally,
a former Fulbright scholar returned from Moldova. Attendees gave scientific presentations
and talks about the benefits of having done research at the Price Institute.
Dr. Jason Smith
Dr. Jason Smith, Dr. Hiram C. Polk, Jr. and Mrs. Lily Banerjee Professor
and Chair in Surgery, Division of General Surgery, has been selected as the winner
of the 2015 J. Bradley Aust Award for his abstract and presentation entitled, "Direct
Peritoneal Resuscitation Reduces Inflammatory MiRNAs After Hemorrhagic Shock." He
made the presentation at the Annual Scientific Sessions of the 2015 Western Surgical
Association in the fall.
"Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective
Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon
Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph
Node Biopsy" has been published in the Journal of Clinical Oncology. Click here to review an early release of the
Dr. Kelly McMasters is the principal investigator of this large clinical
study. He is the Ben A. Reid, Sr., MD Professor and Chairman of The Hiram C. Polk,
Jr., MD Department of Surgery at the University of Louisville School of Medicine.
Dr. McMasters initiated The Sunbelt Melanoma Trial, at the time the world’s largest
melanoma study (involving more than 3600 patients), in 1997.
"Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective
Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon
Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph
Node Biopsy" has been selected to be included in the 2016 Best of the Journal of
Clinical Oncology Annual Meeting Edition.
Click here to link to the article.
Dr. Erica Sutton
Surgery on Sunday Louisville, Inc., a nonprofit organization that provides free
colonoscopies and outpatient surgical procedures to uninsured and underinsured residents
of Kentucky, was named an honoree by National Colorectal Cancer Roundtable. Each
winner will be recognized on a live broadcast on March 1, 2017.
Surgery on Sunday Louisville is built on a collaborative model in which every hospital
in the Louisville area shares a responsibility in providing in-kind services to
offer colonoscopies to members of the community who could not otherwise afford colorectal
cancer screening. These individuals are also at increased risk. In Kentucky, patients
who lack insurance have more than twice the odds of being diagnosed with advanced
colorectal cancer. Since its founding in 2013, Surgery on Sunday Louisville, Inc.
has recruited more than 500 volunteers to treat more than 270 patients, leading
to the treatment of more than 125 polyps and two cancers. The organization is now
assisting communities in other states to replicate their successful model of partnering
to deliver pro bono care to the patients that need it most.
Dr. Erica Sutton, assistant professor of surgery, is President and Founder
of Surgery on Sunday Louisville.
The National Colorectal Cancer Roundtable (NCCRT) is an organization co-founded
by the American Cancer Society and the Centers for Disease Control and Prevention
whose mission is to increase colorectal cancer screening rates across the United
Erica Sutton, MD
Erica Sutton, MD, will receive the Excellence in Community Service at the
2016 Jewish Hospital & St. Mary’s Foundation’s Doctors' Ball, which will be held
Saturday, Oct. 15 at the Marriott Louisville Downtown. Dr. Sutton, assistant professor
of surgery with expertise in minimally invasive procedures and surgical endoscopy,
was recently named director of community engagement for the Department of Surgery.
She volunteers her services with Surgery on Sunday, an organization that provides in-kind outpatient surgical
and endoscopic care to income-eligible members of the Louisville community who are
uninsured or under insured.
Dr. Gordon Tobin
Gordon Tobin, MD, was awarded the Ephraim McDowell Physician of the Year at the 2017 Jewish Hospital & St. Mary's Foundation Doctors' Ball.
The Ephraim McDowell Physician of the Year honors a physician who has made significant contributions to the field of medicine, provided humanitarian service, and demonstrated the highest ethical standards. This is typically a physician who has shown long-term service to the community.
Born and raised in Idaho, Dr. Tobin completed his undergraduate degree at Whitman College in Washington and his medical degree at the University of California School of Medicine, San Francisco. He completed residencies and General Surgery and Plastic Surgery at the University of Arizona before coming to Louisville.
Dr. Tobin career encompasses surgical education, pioneering medial research, care for the underserved at home and abroad and physician leadership in local, state and national organizations. Professor of Surgery and former Plastic Surgery Director, he founded a robust research laboratory that developed many new reconstructive techniques and pioneered hand and face transplantation. He is Director of Craniofacial Transplantation at UofL and an original member of the team that laid essential research foundations and performed the world's first successful hand transplant in 1999.
Dr. Tobin is a member of the Jewish Hospital and UofL Cardiac Innovation Institute Pancreatic Islet Transplantation Team, which seeks a cure for diabetes. He also studies and writes extensively on medical ethics and medical history. He has written more than 300 scientific and medical papers, book chapters and books.
As founder of the UofL Plastic Surgery Research Laboratory, Dr. Tobin's early research provided many breakthroughs in reconstructive surgery for cancer, burns and trauma. His technique of pelvic and vaginal reconstruction after radical pelvic cancer has become the preferred method worldwide. He pioneered reconstruction of cardiac and thoracic surgery defects, as well as early excision and coverage of burns. He also developed methods of vital organ coverage in separation of conjoined (Siamese) twins, working with UofL Pediatric and Cardiac Surgery teams.
Throughout his career, Dr. Tobin has embraced medical missions abroad and at home. In 1991, he co-founded the Vietnam Burn Care Mission to bring modern burn care to Southeast Asia. The mission team made repeated medical care and teaching visits to Vietnam burn centers over the subsequent decade, leading to vastly improved burn survival. He is a care provider and Board Member of Healing the Children, and he supports the volunteer efforts of Surgery On Sunday. His long-standing support of The Healing Place has helped the recovery program reach beyond alcohol-dependency recovery to address the current opioid and heroin epidemic.
Dr. Tobin is also a long-standing supporter of Kentucky's Supplies Over Seas (SOS) organization. He led the 2005 SOS effort for Afghanistan and is involved in current relief effort for Syrian refugee camps. In 2015, he obtained a grant from the Kentucky Medical Association Foundation to test and refurbish costly, high-tech equipment. This effort recycles sophisticated equipment worth millions of dollars for impoverished overseas hospitals while keeping tons of metal and toxic electronics out of U.S. landfills. He has received multiple humanitarian service awards and election to humanitarian honor societies.
Dr. Tobin has served in local, state and national roles in various medical societies. He is Past President of both the Greater Louisville Medical Society (GLMS) and the Kentucky Medical Association (KMA) and continues service on the KMA Foundation Board. His key advocacies are promoting health-enhancing behavior, protecting a health-sustaining environment and finding consensus solutions to fully insure health care for all citizens.
Dr. Jessica Weaver
Dr. Jessica Weaver was awarded the John M. Houchens Prize, which is awarded to the
doctoral student who represents the most meritorious dissertation for the December
commencement. The John M. Houchens Prize honors a former Registrar of the University.
In the fall and spring of each year doctoral dissertations are submitted to the
School of Interdisciplinary and Graduate Studies for consideration. If one is deemed
to be of special merit, a committee may recommend that its author be awarded the
Houchens Prize. Dr. Weaver is a fourth year general surgery resident.
Dr. Jessica Weaver won the American College of Surgeons Committee on Trauma
Regional Paper Competition, Basic Science Section. She now will be eligible to compete
at the National Paper Competition. Her paper is entitled, "Direct Peritoneal Resuscitation
Reduces Macrophages and Neutrophils in Kidneys after Brain Death." Dr. Weaver is
a fourth year general surgery resident.